Onconova Therapeutics, Inc. (ONTX) announced Tuesday that it has acquired Trawsfynydd Therapeutics, Inc., a privately-held biotechnology company developing antivirals for influenza, COVID and other infectious diseases, in an all-stock transaction.

Related Keywords

Torrey Pines , Werner Cautreels , Nasdaq , Traws Pharma Inc , More Such Health News , Onconova Therapeutics Inc , Trawsfynydd Therapeutics Inc , Onconova Therapeutics , Trawsfynydd Therapeutics , Traws Pharma , Chief Executive Officer , Onconova , Nconova Trawsfynydd , Trawsfynydd ,